Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
...
Next
(1176)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jan 21, 2023 1:28pm
RE:RE:RE:RE:RE:RE:RE:Friday Knee Slapper
Maybe end of December 2018??
(1176)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jan 21, 2023 1:25pm
RE:RE:RE:RE:RE:RE:Friday Knee Slapper
"go on the chart and slide over your mouse and you will see that the last time we were at this price was around the end of january 2023. so here we are again.." Do you wish to edit this or
...more
(1176)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jan 21, 2023 1:20pm
RE:PRC Partners anticipates that a major licensing deal ....
Is this something that is being written as of currently or is it a repeat of something that was written back in early 2022?? It's a bit confusing as to where you are going with it. ie. is it you
...more
(6)
•••
biofool
X
View Profile
View Bullboard History
Comment by
biofool
on Jan 21, 2023 11:31am
RE:RE:RE:RE:RE:RE:Friday Knee Slapper
you and honest? that´s another knee slapper
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 21, 2023 10:59am
RE:RE:RE:RE:RE:Friday Knee Slapper
You remember that the pp at 40 was in and around the time tinyi letter was signed right, which is chinese interest, no? biofool, we are all pissed off right now at the share price and you are
...more
(6)
•••
biofool
X
View Profile
View Bullboard History
Comment by
biofool
on Jan 21, 2023 10:18am
RE:RE:RE:RE:Friday Knee Slapper
you are well informed about PRC
(6)
•••
biofool
X
View Profile
View Bullboard History
Comment by
biofool
on Jan 21, 2023 9:47am
RE:RE:RE:Be kind to Bealert
"The funny part is Howie convinced the rest of the board (which are probably under his thumb) that they didn't need an upfront payment that they could wait to get a larger royalty instead
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jan 21, 2023 9:31am
RE:RE:Be kind to Bealert
Yeah not too many companies do a "major" deal with a large pharma and then have to do financing to continue operations. The funny part is Howie convinced the rest of the board (which
...more
(6)
•••
biofool
X
View Profile
View Bullboard History
Post by
biofool
on Jan 21, 2023 9:15am
PRC Partners anticipates that a major licensing deal ....
PRC Partners anticipates that a major licensing deal with one of the Top 10 pharmaceutical companies and Sirona
...more
(6)
•••
biofool
X
View Profile
View Bullboard History
Comment by
biofool
on Jan 21, 2023 9:05am
RE:RE:RE:RE:Be kind to Bealert
yes i do because it would make sense. read yourself read the deleted prc propaganda read and watch the deleted comcap media propaganda I can sense the same originator. read this https://www
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 21, 2023 7:24am
RE:RE:RE:Be kind to Bealert
are you seriously implying I have anything to do with prc? I am a gd private investor. give your head a shake.
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 21, 2023 6:58am
RE:RE:Be kind to Bealert
Yes, good question. from the november 10th announcement on the scientific partnership for anti viral, they indicated 12 weeks approximately to receive the results of their scientific review. that
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 21, 2023 6:00am
RE:who is biorun
really, are you serious?, the fact that some of you guys attack my online character so aggressively and make this stuff up here tells me some either have adverse positions or some other ongoing
...more
(6)
•••
biofool
X
View Profile
View Bullboard History
Post by
biofool
on Jan 21, 2023 3:46am
who is biorun
an independent investor or https://momentumpr.com/sirona-hires-prc-partners-consulting-services/ You decide what makes sense for you.
Prev
...
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario